Marta Aldea Novo

Reactogenicity and Immunogenicity of BNT162b2 in Subjects Having Received a First Dose of ChAdOx1s: Initial Results of a Randomised, Adaptive, Phase 2 Trial (CombiVacS)

A. Borobia, A. Carcas, D. Lora, 2021, SSRN Electronic Journal.